Chemistry: molecular biology and microbiology – Virus or bacteriophage – except for viral vector or...
Reexamination Certificate
2006-03-14
2006-03-14
Mosher, Mary E. (Department: 1648)
Chemistry: molecular biology and microbiology
Virus or bacteriophage, except for viral vector or...
C530S350000, C530S402000, C530S403000, C530S404000, C530S405000, C530S406000, C424S192100, C424S193100, C424S400000, C424S489000, C424S456000, C424S499000, C424S780000
Reexamination Certificate
active
07011968
ABSTRACT:
The invention relates to a synthetic, biologically active molecule for fixing an active ingredient to the virus protein 1 (VP1) of the polyoma virus. According to the invention, an amino acid sequence A1 which is derived from the C-terminal end of virus protein 2 (VP2) or 3 (VP3) of the polyoma virus is bonded to an active ingredient at one of its ends.
REFERENCES:
patent: 4950599 (1990-08-01), Bertling
patent: 5618536 (1997-04-01), Lowy et al.
patent: 6165772 (2000-12-01), Bertling
patent: 43 35 025 (1995-04-01), None
patent: 195 43 553 (1997-05-01), None
patent: 0 259 149 (1988-03-01), None
patent: 2 257 431 (1993-01-01), None
patent: WO 94/04686 (1994-03-01), None
patent: WO 96/11274 (1996-04-01), None
patent: WO9743431 (1997-11-01), None
Chang et al (Transactions of the Kansas Academy of Science 96:35-39, 1993).
Jans et al (Medicinal Research Reviews 18(4):189-223, 1998).
Shah. Fields Virology, Third edition, ed. Fields et al, Lippincott-Raven Oublishers, Philadelphia, 2996, pp. 2027-2043.
Cole. Fields Virology, Third edition, ed. Fields et al, Lippincott-Raven Oublishers, Philadelphia, 2996, pp. 1997-2025.
Chen et al (EMBO Journal 17:3233-3240, 1998).
Barouch et al (Journal of Virology 68:3982-3989, 1994).
Albericio et al., “Use of the Npys thiol protection in solid phase peptide synthesis,”Int. J. Peptide Protein Res.,1989, 34:124-128.
Atherton and Sheppard,Solid Phase Peptide Synthesis—A Practical Approach,1989, IRL Press at Oxford University Press, Oxford (Table of Contents only).
Chen et al., “Interaction of polyomavirus internal protein VP2 with the major capsid protein VP1 and implications for participation of VP2 in viral entry,”EMBO J.,1998, 17(12):3233-3240.
DeFoort et al., “A rational design of synthetic peptide vaccine with a built-in adjuvant,”Int. J. Peptide Protein Res.,1992, 40:214-221.
Lindner and Robey, “Automated synthesis and use of N-chloroacetyl-modified peptides for the preparation of synthetic peptide polymers and peptide-protein immunogens,”Int. J. Peptide Protein Res.,1987, 30:794-800.
Redmond et al., “Rotavirus Particles Function as Immunological Carriers for the Delivery of Peptides from Infectious Agents and Endogenous Proteins,”Mol. Immunol.,1991, 28(3):269-278.
Schnorrenberg and Gerhardt, “Fully Automatic Simultaneous Multiple Peptide Synthesis in Micromolar Scale—Rapid Synthesis of Series of Peptides for Screening in Biological Assays,”Tetrahedron,1989, 45(24):7759-7764.
Zhang and Tam, “Synthesis and Application of Unprotected Cyclic Peptides as Building Blocks for Peptide Dendrimers,”J. Am. Chem. Soc.,1997, 119:2363-2370.
Abbing et al., “Efficient Intracellular Delivery of a Protein and a Low Molecular Weight Substance via Recombinant Polyomavirus-like Particles,”J. Biol. Chem.,2004, 279(26):27410-21.
Bertling Wolf
Reiser Christian
Walter Jurgen
Fish & Richardson P.C. P.A.
Mosher Mary E.
november Aktiengesellschaft Gesellschaft fur Molekulare Medizin
LandOfFree
Fragments of virus protein 2 or 3 of the polyoma virus, used... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fragments of virus protein 2 or 3 of the polyoma virus, used..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fragments of virus protein 2 or 3 of the polyoma virus, used... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3562493